Preparation and In Vitro Evaluation of Aspartic/Alginic Acid Based Semi-Interpenetrating Network Hydrogels for Controlled Release of Ibuprofen.
acrylic acid
alginic acid
aspartic acid
ethylene glycol dimethacrylate
hydrogel
Journal
Gels (Basel, Switzerland)
ISSN: 2310-2861
Titre abrégé: Gels
Pays: Switzerland
ID NLM: 101696925
Informations de publication
Date de publication:
09 Jun 2021
09 Jun 2021
Historique:
received:
28
04
2021
revised:
28
05
2021
accepted:
29
05
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
3
7
2021
Statut:
epublish
Résumé
Different combinations of polymers, aspartic acid (ASP), alginic acid (AL), and monomer acrylic acid (AA) were crosslinked in the presence of an initiator ammonium peroxodisulfate (APS) and cross-linker ethylene glycol dimethacrylate (EGDMA) to develop aspartic acid/alginic acid-co-poly(acrylic acid) (ASP/ALPAA) (semi-interpenetrating polymer network (SIPN)) hydrogels by the free radical polymerization technique for the controlled delivery of ibuprofen (IBP). Various studies such as dynamic swelling studies, drug loading, in vitro drug release and sol-gel analysis were carried out for the hydrogels. Higher swelling was observed at higher pH 7.4 as compared to lower pH 1.2, due to the presence of carboxylic groups of polymers and the monomer. Hence, pH-dependent swelling was exhibited by the developed hydrogels which led to a pH-dependent drug release and vice versa. The structural properties of the hydrogels were assessed by FTIR, PXRD, TGA, DSC, and SEM which confirmed the fabrication and stability of the developed structure. FTIR analysis revealed the reaction of both polymers with the monomer during the polymerization process and confirmed the overlapping of the monomer on the backbone of the both polymers. The disappearance of high intense crystalline peaks and the encapsulation of the drug by the hydrogel network was confirmed by PXRD. TGA and DSC showed that the developed hydrogels were thermally more stable than their basic ingredients. Similarly, the surface morphology of the hydrogels was analyzed by SEM and showed a smooth surface with few pores. Conclusively, ASP/ALPAA hydrogels have the potential to deliver IBP for a long period of time in a controlled way.
Identifiants
pubmed: 34207688
pii: gels7020068
doi: 10.3390/gels7020068
pmc: PMC8293266
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Kaohsiung Medical University Research Foundation
ID : KMU-TC109A03-1
Organisme : National Science Council of Taiwan
ID : MOST 109-2320-B-037-0025
Références
J Microencapsul. 2005 Feb;22(1):25-36
pubmed: 16019888
Drug Res (Stuttg). 2014 Jul;64(7):384-8
pubmed: 24443305
J Control Release. 2004 Apr 28;96(2):285-300
pubmed: 15081219
Pharmaceuticals (Basel). 2021 Mar 08;14(3):
pubmed: 33800248
Carbohydr Polym. 2014 Jan;99:666-78
pubmed: 24274557
J Pharm Sci. 2005 Oct;94(10):2121-31
pubmed: 16136567
Eur J Pharm Biopharm. 2007 Feb;65(2):204-14
pubmed: 16996255
J Microencapsul. 2011;28(1):74-81
pubmed: 21171818
J Control Release. 2014 Sep 28;190:254-73
pubmed: 24746623
BMC Biophys. 2018 Feb 9;11:2
pubmed: 29449937
Ther Deliv. 2019 Nov;10(11):697-717
pubmed: 31789106
Indian J Pharm Sci. 2015 Jan-Feb;77(1):83-90
pubmed: 25767322
Drug Dev Ind Pharm. 2020 Feb;46(2):272-282
pubmed: 31928342
Adv Drug Deliv Rev. 2010 Jan 31;62(1):83-99
pubmed: 19799949
Int J Biol Macromol. 2010 Nov 1;47(4):520-7
pubmed: 20678518
Acta Pol Pharm. 2016 Sep;73(5):1311-1324
pubmed: 29638071
Adv Drug Deliv Rev. 2008 Dec 14;60(15):1638-49
pubmed: 18840488
Gels. 2021 Jan 27;7(1):
pubmed: 33514036
Mater Sci Eng C Mater Biol Appl. 2012 Aug 1;32(6):1443-51
pubmed: 24364944
J Sci Food Agric. 2020 Sep;100(12):4425-4432
pubmed: 32388863
Pak J Pharm Sci. 2006 Apr;19(2):119-24
pubmed: 16751122
Biomacromolecules. 2009 Sep 14;10(9):2515-32
pubmed: 19708684
Drug Dev Ind Pharm. 2021 Mar;47(3):465-476
pubmed: 33651645
J R Soc Med. 2007;100 Suppl 48:2-6
pubmed: 18335846
J Biomater Sci Polym Ed. 2009;20(2):235-51
pubmed: 19154672
Pharmaceuticals (Basel). 2021 Apr 09;14(4):
pubmed: 33918921
Pak J Pharm Sci. 2020 Jul;33(4):1483-1491
pubmed: 33583778
Drug Dev Ind Pharm. 2002 Jul;28(6):621-30
pubmed: 12149954
Pharmaceuticals (Basel). 2020 Nov 17;13(11):
pubmed: 33212866